Melinda Merchant
Affiliations: | 1996 | University of Miami, Coral Gables, FL |
Google:
"Melinda Merchant"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Boal LH, Glod J, Spencer M, et al. (2020) Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I related Plexiform Neurofibromas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Chi SN, Bourdeaut F, Laetsch TW, et al. (2020) Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed/refractory integrase interactor 1-negative tumors. Journal of Clinical Oncology. 38: 10525-10525 |
| Shukla NN, Somwar R, Smith RS, et al. (2016) Proteasome addiction defined in Ewing's sarcoma is effectively targeted by a novel class of 19S proteasome inhibitors. Cancer Research |
| D'Angelo S, Merchant M, Melchiori L, et al. (2015) Optimizing engineered TCR T cell therapy for synovial sarcoma Journal For Immunotherapy of Cancer. 3: 159 |
| Melchiori L, Williams DD, Binder-Scholl GK, et al. (2015) 511. Enhanced-Affinity NY-ESO-1-Specific T Cells Exhibit Extended Functionality without Exhaustion in a Pattern of Effector and Memory Programming in Multiple Cancer Indications Molecular Therapy. 23 |
| Arnold MA, Ballester LY, Pack SD, et al. (2014) Primary subcutaneous spindle cell Ewing sarcoma with strong S100 expression and EWSR1-FLI1 fusion: a case report Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 17: 302-307 |
| Shukla N, Somwar R, Ambati S, et al. (2014) Abstract PR09: High-throughput chemical screening identifies a novel class of proteasome inhibitors with significant activity against Ewing sarcoma Cancer Research. 74 |
| van Den Brink M, Leen AM, Baird K, et al. (2013) Enhancing immune reconstitution: from bench to bedside. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: S79-83 |
| Sholler GL, Bergendahl G, VanderWerff A, et al. (2013) Abstract LB-160: A feasibility trial using molecular-guided therapy for the treatment of patients with refractory or recurrent neuroblastoma. Cancer Research. 73 |
| Baird K, Fry TJ, Merchant M, et al. (2012) Early Clinical Experience of aAPC Activated NK-DLI Following Allogeneic PBSCT in Pediatric Solid Tumor Patients. Blood. 120: 3013-3013 |